Antitumour Potential of Gigartina pistillata Carrageenans against Colorectal Cancer Stem Cell-Enriched Tumourspheres

Mar Drugs. 2020 Jan 12;18(1):50. doi: 10.3390/md18010050.

Abstract

Gigartina pistillata is a red seaweed common in Figueira da Foz, Portugal. Here, the antitumour potential of G. pistillata carrageenan, with a known variable of the life cycle, the female gametophyte (FG) and tetrasporophyte (T) was evaluated against colorectal cancer stem cell (CSC) -enriched tumourspheres. FTIR-ATR analysis of G. pistillata carrageenan extracts indicated differences between life cycle phases, being FG a κ/ι hybrid carrageenan and T a ʎ/ξ hybrid. Both carrageenan extracts presented IC50 values inferior to 1 μg/mL in HT29-derived CSC-enriched tumourspheres, as well as reduced tumoursphere area. The two extracts were also effective at reducing cellular viability in SW620- and SW480-derived tumourspheres. These results indicate that carrageenans extracted from two G. pistillata life cycle phases have antitumour potential against colorectal cancer stem-like cells, specially the T carrageenan.

Keywords: antitumour activity; cancer stem cells; carrageenan; colorectal cancer.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Biological Products / pharmacology*
  • Carrageenan / pharmacology*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Colorectal Neoplasms / drug therapy
  • Humans
  • Inhibitory Concentration 50
  • Neoplastic Stem Cells / drug effects*
  • Rhodophyta / chemistry*
  • Seaweed / chemistry

Substances

  • Antineoplastic Agents
  • Biological Products
  • Carrageenan